Cimzia (certolizumab pegol) gained approval for active nonradiographic axial spondyloarthritis with objective signs of inflammation.
Medscape © 2019 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Mary L Windle. FDA Drug Approvals — 2019 Midyear Review - Medscape - Aug 09, 2019.